Domestic well-known listed pharmaceutical machine enterprises: first-half net profit will maintain the growth trend

[
pharmaceutical enterprise network newsRecently, Tung Fu Long Chief Financial Officer in 2019 annual performance online briefing said that in the second quarter, the company will actively protect and promote domestic and foreign pharmaceutical equipment service delivery At the same time, we continue to strengthen marketing and sales distribution company disinfection, cell preparation classes and other medical equipment products, improve the company's overall sales revenue and economic benefitsConsidering the company's first quarter operating results and the outlook and analysis of the second quarter, the company expects 20201--6 month cumulative net profit will keep increasingTofflon the end of April 2019 published annual financial report, 2019 year the company achieved total revenue of 2.264 billion yuan, up 18.11 percent; attributable to shareholders of listed companies net profit of 146 million yuan, surged 106.95 percent year on yearThe main reason for the growth performance carding system integration companies to implement accurate analysis of internal management, by improving information management capabilities, conduct overall business, declined due to the proportion of material costs, expenses and revenue wereIn addition, Tung Fu Long also released the 2020 first quarter reportThe report shows that the company achieved first quarter operating income of 503 million yuan, up 14.72 percent; attributable to shareholders of listed companies net profit of 47.1485 million yuan, surged 195.98 percent year on yearTung Fu Long said the report period, the company's pharmaceutical equipment sector to actively protect and promote domestic and international business delivery plans, continue to implement precise management, enhance information management capacity, strengthen cost control; medical technology and technology sector, disinfection, cell preparation of medical equipment efficiency etcappear gradually and improvementioned in the report, during the reporting period, the pharmaceutical industry to accelerate reform, promote the transformation and upgrading of the domestic pharmaceutical equipment industry, industry concentration increase, competition is becoming increasingly fierceIn this regard, Tung Fu Long is committed to the pharmaceutical equipment industry "Made in 2025" around drug safety, quality equipment, fully support and promote injections,API, bio-engineering, solid preparation, decontamination, MES systematic construction fields of information management systems, and actively explore new international markets, learn the advantages of technology and international counterparts to strengthen international market share at the same time consolidating the domestic market brand positionthe same time, industry transformation and upgrading, the company's internal management put forward higher requirementsIn this regard, the company comprehensively promote the accurate management, to management for efficiencyAddressing development issues with management tools to promote the management structure of the headquarters functions of building management systems, processes and IT support, to create a marketing system and sales and service platform, R & D system and development platform, manufacturing and supply chain platform, human resources platform, financial platform, improve the management level, the establishment of systems and organizational competitiveness data show, Tung Fu Long is a provider of pharmaceutical technology for the global pharmaceutical business, core equipment, systems engineering overall solution integrated pharmaceutical equipment for service providers Its main business is divided into three sections, namely equipment for the pharmaceutical sector, medical technology and technology sector, food and equipment engineering sector reported that Tung Fu Long will be in the medical technology sector continued layout and technology and investment, improve the overall turnkey engineering capabilities, boost sustainable growth and long-term operating performance of the company Industry analysts believe that in the short term, the pharmaceutical industry and some areas may develop faster, such as the Internet health, vaccine development and other fields In addition, segments of short-term external demand type may be affected During the year, pharmaceutical, consumer, technology and other domestic demand, the rigid areas are the focus of concern.